Live Breaking News & Updates on Company Healthcare House Call Conference On

Stay updated with breaking news from Company healthcare house call conference on. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Press Release : Addex to Participate at the Benchmark Company Healthcare House Call Conference

Message :
Required fields
Geneva, Switzerland, May 24, 2021 Addex Th
https://www.globenewswire.com/Tracker?data=GKEDSALQ3NE4EtVCK9RzLXOk8Q1WB4CkSAscPRzRqf0SdKsQfRwX9gF3D5OianoM6yqhedJ0aWDLbl85uBW8pGIBsUsozfgyWuKSHEalz5Y=
e
https://www.globenewswire.com/Tracker?data= w0gykO1cRWXvNInzg 3desjb1 u59TFS0A9iWd0zSqOojFGKcGUUTA-pVC88i-7tgLyk1ZFhlOA qCsbfnT9w==
rapeutics
https://www.globenewswire.com/Tracker?data=Hs rkfRwMjZ7W-Q8M7njxKHxgbDMLkKODX R98HbsH48L3DiAk0zV907yb2MqLBez4xLV5rL mMX9NC-yZhLsWbD6D6sL4p11kl1LT-ApNA=
(SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company
pioneering allosteric modulation-based drug discovery and development,
announced today that Tim Dyer, Chief Executive Officer, will participate ....

United States , Tim Dyer , Company Annual Report On Form , Company Healthcare House Call Conference On , Janssen Pharmaceuticals Inc , Swiss Exchange , Chief Executive Officer , About Addex Therapeutics , Addex Therapeutics , Janssen Pharmaceuticals , American Depositary Shares , Mike Sinclair , James Carbonara , Halsin Partners , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Addex Therapeutic , Dow Jones , Addex Therapeutics Ltd Stock Exchange , Press Release , Ddex Adxn Ch0029850754 , ஒன்றுபட்டது மாநிலங்களில் , நேரம் சாய தொழிலாளி , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , ஜான்சன் மருந்துகள் இன்க் ,

Addex to Participate at the Benchmark Company Healthcare House Call Conference

2
1 – Addex Therapeutics (NASDAQ:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Tim Dyer, Chief Executive Officer, will participate at the virtual Benchmark Company Healthcare House Call Conference on May 26
th, 2021 (09:00 – 16:30 EDT)
Mr. Dyer will be available for virtual one-on-one meetings throughout the conference. For more information or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].
About Addex Therapeutics:
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach ....

United States , Tim Dyer , Mike Sinclair , Company Annual Report On Form , Company Healthcare House Call Conference On , Janssen Pharmaceuticals Inc , Swiss Exchange , Addex Therapeutics , Chief Executive Officer , Janssen Pharmaceuticals , American Depositary Shares , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Addex Therapeutic , ஒன்றுபட்டது மாநிலங்களில் , நேரம் சாய தொழிலாளி , மைக் சின்க்ளேர் , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , ஜான்சன் மருந்துகள் இன்க் , சுவிஸ் பரிமாற்றம் , தலைமை நிர்வாகி அதிகாரி , ஜான்சன் மருந்துகள் , பார்க்கிறது அறிக்கைகள் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஆண்டு அறிக்கை ,